Technical Analysis for TTPH - Tetraphase Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 1.37 0.74% 0.01
TTPH closed up 0.74 percent on Tuesday, March 19, 2019, on 68 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical TTPH trend table...

Date Alert Name Type % Chg
Mar 19 Upper Bollinger Band Walk Strength 0.00%
Mar 19 Inside Day Range Contraction 0.00%
Mar 19 Upper Bollinger Band Touch Strength 0.00%
Mar 18 Upper Bollinger Band Walk Strength 0.74%
Mar 18 Upper Bollinger Band Touch Strength 0.74%
Mar 15 50 DMA Support Bullish -2.84%
Mar 15 Expansion Pivot Buy Setup Bullish Swing Setup -2.84%
Mar 15 Pocket Pivot Bullish Swing Setup -2.84%
Mar 15 Volume Surge Other -2.84%
Mar 15 Earnings Movers Other -2.84%

Older signals for TTPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of various antibiotics for the treatment of serious and life-threatening multi-drug resistant infections through its chemistry technology. Its principal products include eravacycline, an intravenous and oral antibiotic that use as a empiric monotherapy has completed the Phase II clinical trials for the treatment of multi-drug resistant Gram-negative infections; and eravacycline oral formulation that is in Phase I clinical trials to treat complicated urinary tract infections in intravenous-to-oral step-down therapy. The company's products that are under development comprise TP-834; and TP-271 that is in preclinical trials for the treatment of respiratory diseases caused by bacterial biothreat pathogens, as well as engages in the development of Pseudomonas/Gram-negative program. Tetraphase Pharmaceuticals, Inc. was founded in 2006 and is based in Watertown, Massachusetts.
Medicine Chemistry Pharmacology Antibiotics Respiratory Diseases Multiple Drug Resistance Pyrrolidines Carbapenem Pseudomonas Basilea Pharmaceutica Eravacycline Multi Drug Resistant Gram Negative Infections
Is TTPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.49
52 Week Low 1.01
Average Volume 662,540
200-Day Moving Average 2.3688
50-Day Moving Average 1.2729
20-Day Moving Average 1.2573
10-Day Moving Average 1.294
Average True Range 0.0946
ADX 21.08
+DI 25.0661
-DI 9.4828
Chandelier Exit (Long, 3 ATRs ) 1.1662
Chandelier Exit (Short, 3 ATRs ) 1.4038
Upper Bollinger Band 1.395
Lower Bollinger Band 1.1196
Percent B (%b) 0.91
BandWidth 21.90408
MACD Line 0.026
MACD Signal Line 0.0074
MACD Histogram 0.0186
Fundamentals Value
Market Cap 69.94 Million
Num Shares 51.1 Million
EPS -2.82
Price-to-Earnings (P/E) Ratio -0.49
Price-to-Sales 58.89
Price-to-Book 2.16
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.46
Resistance 3 (R3) 1.46 1.43 1.45
Resistance 2 (R2) 1.43 1.41 1.43 1.44
Resistance 1 (R1) 1.40 1.39 1.42 1.40 1.43
Pivot Point 1.37 1.37 1.38 1.37 1.37
Support 1 (S1) 1.34 1.35 1.36 1.34 1.31
Support 2 (S2) 1.31 1.33 1.31 1.30
Support 3 (S3) 1.28 1.31 1.30
Support 4 (S4) 1.28